Camp4 Therapeutics Corporation · NASDAQ:CAMP
Balyasny Asset Management L.P.'s stake in Camp4 Therapeutics Corporation fell to 4.99% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Balyasny Asset Management L.P.'s stake in Camp4 Therapeutics Corporation fell to 4.99%, 2,591,097 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 4.99%
- Shares
- 2,591,097
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | 4.99% | 2,591,097 |
| BAM GP LLC | 4.99% | 2,591,097 |
| Balyasny Asset Management Holdings LP | 4.99% | 2,591,097 |
| Dames GP LLC | 4.99% | 2,591,097 |
| Dmitry Balyasny | 4.99% | 2,591,097 |
Source
Related
- Camp4 Therapeutics Corporation
- Balyasny Asset Management L.P.
- Camp4 Therapeutics Corporation shareholders
- Schedule 13G · Balyasny Asset Management L.P. · May 15, 2026
- Form 4 · Gold Kelly · Sep 2, 2026
- Form 4 · Schwab Andrew J. · Aug 31, 2026
- Schedule 13D/A · Schwab Andrew J. · Aug 31, 2026
- Form 4 · Schwab Andrew J. · Aug 26, 2026
- Form 4 · Schwab Andrew J. · Aug 21, 2026